Luminist Labs
Diagnostic platform for early detection of liver disease
HealthtechAcquired
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
Open Roles
No open roles right now.
Verified Team
No verified team members yet.